| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/02/2008 | WO2008049990A2 Use of an anti-cd151 antibody in the treatment of cancer |
| 05/02/2008 | WO2008049928A1 Anti-glycoprotein vi scfv fragment for treatment of thrombosis |
| 05/02/2008 | WO2008049920A2 Il-21 variants |
| 05/02/2008 | WO2008049897A1 Intranasal delivery of polypeptides and proteins |
| 05/02/2008 | WO2008049209A2 Endophyte enhanced seedlings with increased pest tolerance |
| 05/02/2008 | WO2008030706A3 Anti-myostatin antibodies |
| 05/02/2008 | WO2008028977A3 Serum albumin binding proteins with long half-lives |
| 05/02/2008 | WO2008027986A3 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 05/02/2008 | WO2008019326A3 Ephb3-specific antibody and uses thereof |
| 05/02/2008 | WO2007149932A3 Methods and compositions for targeting hepsin |
| 05/02/2008 | WO2007147122A3 Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds |
| 05/02/2008 | WO2007145862B1 Extending survival of cancer patients with elevated levels of egf or tgf-alpha |
| 05/02/2008 | WO2007144619A3 Antibodies selectively binding aggregated prion protein 106-126 and uses thereof |
| 05/02/2008 | WO2007130697A8 Anti-ephb4 antibodies and methods using same |
| 05/02/2008 | WO2007111714B1 Il-21 antagonists |
| 05/02/2008 | WO2007045477A8 Human antibodies against il-13 and therapeutic uses |
| 05/02/2008 | WO2005084329A8 Method for inhibiting tumor formation and growth |
| 05/02/2008 | CA2667568A1 Endophyte enhanced seedlings with increased pest tolerance |
| 05/02/2008 | CA2667558A1 Plants with improved nitrogen utilization and stress tolerance |
| 05/02/2008 | CA2667466A1 Intranasal delivery of polypeptides and proteins |
| 05/02/2008 | CA2667280A1 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 05/02/2008 | CA2667263A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 05/02/2008 | CA2667020A1 Human immune therapies using a cd27 agonist alone or in combination with other immune modulators |
| 05/02/2008 | CA2667019A1 Antibodies and immunoconjugates and uses therefor |
| 05/02/2008 | CA2666672A1 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
| 05/02/2008 | CA2666426A1 Il-21 variants |
| 05/02/2008 | CA2663536A1 Materials and methods for improved immunoglycoproteins |
| 05/01/2008 | US20080104734 Recombinant antibodies to sclerotinia antigens |
| 05/01/2008 | US20080104721 Nucleic acids isolated from crustaceans; linked to expression regulatory elements; analyzing cells by detection of signal; kits |
| 05/01/2008 | US20080103294 Amino acid substitutions which increases protease resistance; linked to water soluble polymer (polyethylene glycol); improved half-life |
| 05/01/2008 | US20080103291 Nucleic acid of given sequence; membrane preparations or cell lysate from recombinant cell transformed with DNA expression vector |
| 05/01/2008 | US20080103099 Apoptin-associating protein |
| 05/01/2008 | US20080103098 Recombinant Expression of Proteins in a Disulfide-Bridged, Two-Chain Form |
| 05/01/2008 | US20080103090 Polynucleotide; hybridization; recombinant vectors, host cells; diagnosis, prognosis; anticarcinogenic and antiproliferative agents; drug screening; genetic engineering |
| 05/01/2008 | US20080102520 Novel human membrane proteins and polynucleotides encoding the same |
| 05/01/2008 | US20080102490 Interferon-like protein zcyto21 |
| 05/01/2008 | US20080102489 Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
| 05/01/2008 | US20080102484 Dendritic cell transmembrane serine protease |
| 05/01/2008 | US20080102479 Method of diagnosing lawsonia intracellularis |
| 05/01/2008 | US20080102477 Method for screening an anticancer drug using acetylated BubR1 |
| 05/01/2008 | US20080102475 Alternatively spliced isoform of phosphodiesterase 4B (PDE4B) |
| 05/01/2008 | US20080102471 Expression vector comprising nucleotide sequences coding myeblastosis (MYB) regulatory proein for use as tool in controlling heterologus gene expression in plants |
| 05/01/2008 | US20080102463 Expression vector comprising nucleotide sequences coding glutamate peptidase for use in identifying modulators for prevention and treatment of schizophrenic brain disorders |
| 05/01/2008 | US20080102458 Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains |
| 05/01/2008 | US20080102457 Target Protein And Target Gene In Drug Designing And Screening Method |
| 05/01/2008 | US20080102083 Compositions and Methods for the Preparation of Human Growth Hormone Glycosylation Mutants |
| 05/01/2008 | US20080102078 Mutated e. coli heat-labile enterotoxin |
| 05/01/2008 | US20080102077 Nucleic and Protein Sequences from the Hxhv Virus and Uses Thereof |
| 05/01/2008 | US20080102076 Immunostimulatory Compositions and Uses Thereof |
| 05/01/2008 | US20080102075 Enzymatic polypeptide which cleaves tumor necrosis factor receptor for use in treatment and prevention of arthritis and inflammatory disorders |
| 05/01/2008 | US20080102072 Cytokine specific immunoglobulin for prevention and treatment of diabetes, autoimmune and inflammatory disorders |
| 05/01/2008 | US20080102071 T cell inhibitory receptor compositions and uses thereof |
| 05/01/2008 | US20080102065 Erythropoietin receptor extended duration limited agonists |
| 05/01/2008 | US20080102060 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 05/01/2008 | US20080102040 Inhibition of factor b, the alternative complement pathway and methods related thereto |
| 05/01/2008 | US20080102027 Targer For B-Cell Disorders |
| 04/30/2008 | EP1916304A2 Antigenic polypeptides associated with multiple sclerosis and uses |
| 04/30/2008 | EP1916303A1 Nucleic acids encoding rearranged human immunoglobulin sequences from transgenic transchromosomal mice |
| 04/30/2008 | EP1916300A1 Chimeric animal and method for producing the same |
| 04/30/2008 | EP1916259A1 Anti-glycoprotein VI SCFV fragment for treatment of thrombosis |
| 04/30/2008 | EP1916256A2 Search for cancer markers by a novel screening method |
| 04/30/2008 | EP1916020A2 Preventives and/or remedies for systemic lupus erythematosus containing anti-IL-6 receptor antibody as the active ingredient |
| 04/30/2008 | EP1916001A2 Human antibodies specific to KDR and uses thereof |
| 04/30/2008 | EP1915621A2 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 04/30/2008 | EP1915619A2 Method for carrying out homogeneous phase detection, in particular, for detecting the progesterone in the milk of a mammal and corresponding kit |
| 04/30/2008 | EP1915456A1 Cancerous disease modifying antibodies |
| 04/30/2008 | EP1915455A1 Cancerous disease modifying antibodies |
| 04/30/2008 | EP1915398A2 Human anti-b7rp1 neutralizing antibodies |
| 04/30/2008 | EP1915397A2 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/30/2008 | EP1915396A2 Use of panton-valentine leukocidin for treating and preventing staphylococcus infections |
| 04/30/2008 | EP1915395A2 Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases |
| 04/30/2008 | EP1915394A2 High-level expression of recombinant antibody in a mammalian host cell |
| 04/30/2008 | EP1915177A2 Alpha-synuclein antibodies and methods related thereto |
| 04/30/2008 | EP1915174A1 Food products comprising probiotic micro-organisms and antibodies |
| 04/30/2008 | EP1399559B1 Mouse lambda light chain locus |
| 04/30/2008 | EP1212417B1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 04/30/2008 | EP1159430B1 Histidin protein-phosphatase |
| 04/30/2008 | EP1058728B1 V-like domain binding molecules |
| 04/30/2008 | CN101171263A Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues |
| 04/30/2008 | CN101171261A Immunoglobulin fraction and process therefor |
| 04/30/2008 | CN101171035A Methods and compositions for modulating TWEAK and FN14 activity |
| 04/30/2008 | CN101168567A Method for preparing hapten specificity antibody |
| 04/30/2008 | CN101168566A Preparation for antibody of antineoplastic specificity marker protein TS/MEDP and use thereof |
| 04/30/2008 | CN101168562A CBP C end protein, monoclonal antibody thereof, preparation and use of the same |
| 04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
| 04/30/2008 | CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins |
| 04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384878C Antibodies specific for human cd22 and their therapeutic anddiagnostic uses |
| 04/30/2008 | CN100384877C Antibody ('11c7') anti nogo a and its pharmaceutical use |
| 04/30/2008 | CN100384876C Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographics |
| 04/30/2008 | CN100384875C 蛋白质 Protein |
| 04/30/2008 | CN100384874C Protein a chromatography |
| 04/30/2008 | CA2564924A1 Design of interferon-inducible protein-10 (ip-10 or cxcl10) chemokine analogs for the treatment of human diseases |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365169 T-bet antibodies |
| 04/29/2008 | US7365168 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| 04/29/2008 | US7365167 Specified complementary determining region (CRD) amino acid sequences; specific binding activity for a cryptic collagen epitope; angiogenesis inhibition, antimetastasis, and tumor-targeted therapy uses |
| 04/29/2008 | US7365166 Immunoglobulins which bind to endothelial growth factor for threatment of cell proliferation; antitumor agenst |
| 04/29/2008 | US7365163 Isolation nulceic acid; genetic engineering; screening antagonist; aminobutyric acid receptor; diagnostics for detecting aberrant GABAA receptor epsilon subunit (GABRE) and ET2 expression, therapy of disorders involving ET2 and GABRE |